• Thumbnail for DLL3
    Delta-like 3 (Drosophila), also known as DLL3, is a protein which in humans is encoded by the DLL3 gene. Two transcript variants encoding distinct isoforms...
    7 KB (879 words) - 23:24, 26 February 2024
  • Govindan R, Boyer M, et al. (June 2023). "Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer:...
    9 KB (518 words) - 21:45, 16 June 2024
  • Thumbnail for Vertebral column
    homologues of three genes associated to the mouse segmentation clock, (MESP2, DLL3 and LFNG), have been shown to be mutated in cases of congenital scoliosis...
    42 KB (5,321 words) - 17:58, 22 June 2024
  • (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased...
    6 KB (404 words) - 01:44, 29 November 2023
  • Thumbnail for Somite
    clock and wavefront model, forms the boundaries of the somites. DLL1 and DLL3 are Notch ligands, mutations of which cause various defects. Notch regulates...
    13 KB (1,452 words) - 15:13, 16 May 2024
  • HGNC:2907 P80370 4319 DLK2 HGNC:21113 Q6UY11 4320 DLL1 HGNC:2908 O00548 4321 DLL3 HGNC:2909 Q9NYJ7 4322 DLL4 HGNC:2910 Q9NR61 4323 DLST HGNC:2911 P36957 4324...
    277 KB (17 words) - 23:17, 27 April 2024
  • Thumbnail for Novartis
    antigen receptor (CAR-T) therapies, that go after delta-like ligand protein 3 (DLL3) including large cell neuroendocrine carcinoma candidate LB2102 for $100 million...
    143 KB (12,021 words) - 19:26, 23 June 2024
  • Thumbnail for Merck & Co.
    that is being researched to treat advanced cancer patients associated with DLL3 expression (delta-like ligand 3), an inherent small cell lung cancer (SCLC)...
    96 KB (9,392 words) - 18:47, 3 July 2024
  • Thumbnail for GenScript Biotech
    antigen receptor (CAR-T) therapies, that go after delta-like ligand protein 3 (DLL3) including large cell neuroendocrine carcinoma candidate LB2102. Novartis...
    21 KB (1,559 words) - 19:35, 24 June 2024
  • Thumbnail for List of therapeutic monoclonal antibodies
    root plate-specific spondin 3 cancer Rovalpituzumab tesirine mab humanized DLL3 small cell lung cancer Rovelizumab LeukArrest mab humanized CD11, CD18 Y...
    135 KB (4,054 words) - 22:35, 2 July 2024
  • Thumbnail for Notch signaling pathway
    coordinate key steps in this process. In mice, mutations in Notch1, Dll1 or Dll3, Lfng, or Hes7 result in abnormal somite formation. Similarly, in humans...
    88 KB (10,270 words) - 03:00, 22 June 2024
  • Thumbnail for Kenro Kusumi
    disorder, spondylocostal dysostosis, caused by mutations in delta-like 3 (DLL3), and he contributed to subsequent research identifying mutations in the...
    11 KB (1,020 words) - 23:34, 12 July 2024
  • Thumbnail for Hepatocyte growth factor receptor
    The Notch pathway, through transcriptional activation of Delta ligand (see DLL3). MET mediates a complex program known as invasive growth. Activation of...
    58 KB (6,927 words) - 03:33, 17 June 2024
  • Type OMIM Gene Locus SCDO1 277300 DLL3 19q13 SCDO2 608681 MESP2 15q26.1 SCDO3 609813 LFNG 7p22 SCDO4 122600 GDF6 8q22.1...
    16 KB (1,232 words) - 09:42, 18 March 2024
  • Thumbnail for EGF-like domain
    CNTNAP3; CNTNAP4; CNTNAP5; COMP; COX-2; CRB1; CRB2; CSPG3; CUBN; DLK1; DLL1; DLL3; DLL4; DNER; EDIL3; EGF; EGFL11; EGFL8; EGFL9; EGFLAM; EPGN; EREG; F7; F9;...
    25 KB (3,071 words) - 19:43, 27 June 2024
  • منتديات دلع" [Rumour: singer Angham is banned from singing in Kuwait]. vb.dll3.com (in Arabic). Archived from the original on 26 May 2007. Retrieved 31...
    14 KB (1,777 words) - 16:41, 2 March 2022
  • 609813; LFNG Spondylocostal dysostosis, autosomal recessive, 1; 277300; DLL3 Spondylocostal dystostosis 4, autosomal dominant; 122600; GDF6 Spondyloepimetaphyseal...
    234 KB (18,877 words) - 15:43, 9 May 2024